Search

Muralidhar R Moola

from Fremont, CA
Age ~57
Get Report
Also known as:
Muralidhar Reddy Moola, Moola M Reddy, Moola Muralidhar Reddy, Muralidha M Reddy, Muralidha Moola
Phone and address:
157 Black Mountain Cir, Fremont, CA 94536
(972) 365-9687
Related to:
Sreenivasa R Avula, 54Srikanth Veerareddy, 46Devananda Muthakana, 59Satish Ab, 50
Connected to:
Cindy Moolchan, 57Hiru J Moolchandani, 64Lorraine B Moolchan, 74Valorie M Moolchan, 92Peter J Moolenaar, 46Carolyn C Moolhuyzen, 64Donna C Moolic, 80Mohammad Moolla, 59Chireen Moolman, 38Pieter L Moolman, 50

Muralidhar Moola Phones & Addresses

  • 157 Black Mountain Cir, Fremont, CA 94536 (972) 365-9687
  • Irving, TX
  • Jupiter, FL
  • Dallas, TX
  • 807 University Blvd APT 106, Jupiter, FL 33458

Business Records

Name / Title
Company / Classification
Phones & Addresses
Muralidhar Reddy Moola
President
Anven Biosciences, Inc
2994 Cheswycke Ter, Fremont, CA 94536

Publications

Us Patents

Compositions And Methods For Screening Peptoid Libraries

View page
US Patent:
20120220482, Aug 30, 2012
Filed:
Feb 14, 2012
Appl. No.:
13/396267
Inventors:
Muralidhar Reddy MOOLA - Jupiter FL, US
JOHN M. ASTLE - Branford CT, US
THOMAS KODADEK - Jupiter FL, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
Certain embodiments are directed to methods for screening synthetic libraries and characterizing the resultant hits that combines many of the attractive features of bead library screening and microarray-based analysis in a seamless fashion.

Diagnostic And Treatment Methods Using A Ligand Library

View page
US Patent:
20120269799, Oct 25, 2012
Filed:
Mar 23, 2012
Appl. No.:
13/428429
Inventors:
Muralidhar Reddy Moola - Jupiter FL, US
Jessica Schilke - Jupiter FL, US
International Classification:
C40B 30/04
C40B 40/10
C07K 16/00
A61K 39/395
A61P 35/00
A61P 25/28
A61P 37/02
A61P 31/12
A61P 31/04
A61P 31/10
A61P 29/00
A61P 9/00
G01N 33/53
A61P 35/04
US Classification:
4241301, 506 9, 435 792, 506 18, 5303891
Abstract:
The invention relates to diagnostic and treatment methods using a ligand library. Specifically, the invention relates to using a ligand library to diagnose or detect a drug induced response, including drug adverse reaction, side effects, drug resistance, and therapeutic efficacy. The invention further relates to identifying biomarkers associated with a drug induced response and providing a personalized medical treatment.

Biomarker Discovery In Complex Biological Fluid Using Bead Or Particle Based Libraries And Diagnostic Kits And Therapeutics

View page
US Patent:
20120270741, Oct 25, 2012
Filed:
Mar 23, 2012
Appl. No.:
13/428313
Inventors:
Muralidhar Reddy MOOLA - Jupiter FL, US
Jessica SCHILKE - Jupiter FL, US
International Classification:
C40B 20/08
C07K 7/06
C40B 30/04
G01N 33/574
C40B 40/10
G01N 33/543
US Classification:
506 6, 506 18, 435 792, 506 9, 530328
Abstract:
The present invention is useful in screening for biomarkers associated with any other disease or condition. Such diseases and conditions range from the neurological diseases, autoimmune diseases and cancers identified above as well as any other disease or condition that has a biomarker such as an antibody or other characterizing protein or biomolecule associated with the disease or progression of the disease. The large ligand libraries of the invention can be used directly in biological fluid, under the appropriate experimental conditions and according to the processes recited herein, to screen for such markers and without the need to use fewer support members (e.g. about 100,000 or less) or without the need to transfer such peptoids or ligands to a microarray before screening the biological fluid. In addition, the ligand libraries may also be used to screen for cell based receptors that specifically relate to a particular cell surface marker.

Identification Of Small Molecules Recognized By Antibodies In Subjects With Neurodegenerative Diseases

View page
US Patent:
20100303805, Dec 2, 2010
Filed:
Jun 1, 2010
Appl. No.:
12/791389
Inventors:
Muralidhar Reddy Moola - Jupiter FL, US
Dwight German - Dallas TX, US
Steven Connell - McKinney TX, US
Rosemary Wilson - Jupiter FL, US
Johnnie Wilson - Jupiter FL, US
Thomas Kodadek - Jupiter FL, US
Assignee:
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61K 39/395
C07K 16/44
C07C 237/20
C07D 317/58
A61P 25/28
G01N 33/53
C40B 30/04
US Classification:
4241301, 5303898, 564153, 549441, 436501, 435 71, 435 792, 506 9
Abstract:
The present invention provides for the identification of individuals having neurodegenerative diseases (ND). Peptoids recognized by Parkinson's Disease- and Alzheimer's Disease-specific antibodies are identified, allowing one to diagnose or predict ND in subjects.

Combinatorial Synthesis And Biomarker Development

View page
US Patent:
20200124618, Apr 23, 2020
Filed:
Sep 16, 2019
Appl. No.:
16/572424
Inventors:
Muralidhar Reddy MOOLA - Fremont CA, US
International Classification:
G01N 33/68
C07K 7/06
C07K 1/04
B01J 19/00
C40B 30/04
Abstract:
Provided herein are methods, kits, and compositions for use in the diagnosis and treatment of diseases. Peptoids recognized by Alzheimer's disease specific antibodies are identified.

Combinatorial Synthesis And Biomarker Development

View page
US Patent:
20190113521, Apr 18, 2019
Filed:
Mar 21, 2017
Appl. No.:
16/088033
Inventors:
Muralidhar Reddy Moola - Fremont CA, US
International Classification:
G01N 33/68
B01J 19/00
C07K 7/06
C07K 1/04
Abstract:
Provided herein are methods, kits, and compositions for use in the diagnosis and treatment of diseases. Peptoids recognized by Alzheimer s disease specific antibodies are identified.
Control profile
Muralidhar R Moola from Fremont, CA, age ~57 Get Report